H.C. Wainwright raised the firm’s price target on Argenx (ARGX) to $774 from $720 and keeps a Buy rating on the shares. The company reported a “jaw-dropping” Q2, the analyst tells investors in a research note. The firm cites Vyvgart’s “robust” sales performance for the target increase.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ARGX:
- Argenx Reports Strong Growth and Strategic Advances
- Argenx Earnings Call: Strong Growth and Innovation
- Argenx’s Vyvgart Sales Surpass Expectations, Driving Buy Rating with Promising Pipeline and Market Expansion
- Argenx price target raised to $756 from $741 at Wells Fargo
- Argenx SE’s Strong Q2 Performance and Positive Outlook Reinforce Buy Rating